Has Carl Hasselman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $718,552 in general payments to Carl Hasselman, MD across 426 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carl Hasselman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carl Hasselman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carl Hasselman, MD

Orthopedic Surgery · Pittsburgh, PANPI 1558339291

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (55.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 83.7% of it on its own, with 6 other manufacturers making up the rest. Among orthopedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$718,552in general payments, 2019–2025

Across 426 payments — averaging $1686.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$602K
Arthrosurface Incorporated$61K
Anika Therapeutics, Inc.$48K
Mid-atlantic Surgical Systems, LLC$8K
Stryker$101
Curonix LLC$40
plus $3 from 1 others

$9,000in research payments, 2019–2025

Across 1 payment — averaging $9000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$9K

What the payments were for

Royalty or licence$397,36355%
Consulting fees$108,75315%
Speaking & faculty fees$161,84123%
Travel & lodging$22,0463%
Food & beverage$5,0801%
Education$5,7191%
Ownership interest$14,4212%
Other$3,3290%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	275	$601,655
Arthrosurface Incorporated	30	$60,718
Anika Therapeutics, Inc.	31	$48,382
Mid-atlantic Surgical Systems, LLC	86	$7,652
Stryker	2	$101
Curonix LLC	1	$40
Amniox Medical, Inc.	1	$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$1,241,136
HemiCAP MTP Resurfacing$82,685
DISTAL EXTREMITIES INSTRUMENTS OTHER INSTRUMENTS ENDOSCOPIC STR$42,698
DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS MESH PLATES$42,698
DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS CFS$42,698
EXTREMITIES & TRAUMA IMPLANTS CORE METAL BUNION$41,707
AR-8906DS$18,081
AR-8908DS$18,081
CAPITAL CONSUMABLES CONSUMABLES RF BRF$14,646
DISTAL EXTREMITIES INSTRUMENTS SOFT TISSUE ENDOSCOPIC STR$12,812
DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE MESH PLATES$12,812
DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE CFS$12,812
DISTAL EXTREMITIES SUTURE FIBERWIRE OTHER$4,277
Toemate$4,000
KISSLoc Suture System$1,379
Arthrosurface Hammertoes$750
WristMotion$526
Toe Motion$375
TWIST$250
DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS BIOSYNC WEDGES$213

How this compares

$718,552 in reported general payments places this provider in the 95th percentile of 43 orthopedic surgery providers in Pennsylvania.

See all orthopedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$222,866

Medicare patients

373

Services billed

1,211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	42	$157
Methylprednisolone	13	$130
Gabapentin	15	$113
Silver Sulfadiazine	13	$76

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Pittsburgh

James BradleyPittsburgh$5.2M
Richard McGoughPittsburgh$261K
Vincent SilvaggioPittsburgh$179K
Patrick SmithPittsburgh$20K
Alex KlinePittsburgh$8K
Trenton GausePittsburgh$4K
Mark RodoskyPittsburgh$2K
William DonaldsonPittsburgh$1K
Aaron TaylorPittsburgh$1K
William AbrahamPittsburgh$1K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →